This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Clinical
Byannli approved by EMA for twice-yearly dosing in schizophrenia
Read more
Strong opiates equivalent to paracetamol and codeine for post-orthopaedic surgery pain
Read more
Haematological cancer patients at increased risk of severe breakthrough COVID-19 infections
Read more
Atezolizumab and nivolumab prolong overall survival compared with docetaxel in NSCLC
Read more
Cancer diagnoses in young people fell but ICU admissions increased during first wave of pandemic
Read more
HRT use increases risk of disease recurrence in breast cancer survivors
Read more
Breast milk found to contain neutralising COVID-19 antibodies
Read more
Endovascular treatment not enhanced by alteplase in stroke patients
Read more
Delayed transfer of care predictive model 70% accurate
Read more
High discrepancy rate in interpretation of advanced scans among specialist radiologists
Read more
Racial and ethnic disparities revealed in study of prostate MRI in men with high PSA
Read more
Dark field X-ray detects emphysema in patients with COPD
Read more
Arginine improves effect of radiotherapy in patients with brain metastases
Read more
Webcast: Blood purification strategies in sepsis
Read more
Paxlovid reduces hospitalisation and death in COVID-19
Read more
Convenience sampling leads to selection bias in ED studies
Read more
ACS presentations via emergency services at ED increased after warning signs campaign
Read more
Page 64 of 200
« First
«
...
10
20
30
...
62
63
64
65
66
...
70
80
90
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Telemedicine strategy post-acute coronary syndrome drives efficiencies and safety, study finds
17 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
x
Search for: